Growth Opportunity NWMI is expanding Mo-99 production capabilities in the U.S. with a planned facility in Missouri, signaling a need for供应 chain, construction, and regulatory support partnerships that can accelerate project milestones and site development services.

Strategic Partnerships As NWMI builds out target fabrication, recovery, purification, and uranium recycling processes, there is a clear opportunity to offer equipment providers, engineering firms, and regulatory consulting to support licensing, integration, and safe operations of the RPF.

RPF Readiness The emphasis on research and development for radioisotope production facility technologies presents a potential for ongoing technology licensing, pilot equipment, and maintenance services to ensure reliable weekly Mo-99 output.

Financial Leverage With funding around a million dollars and plans for a multi-million facility, NWMI may seek financial services, project finance, and risk management solutions to support capital expenditure, lifecycle costs, and grant or incentive opportunities.

Talent & Growth A headcount expansion alongside a high-precision, specialized manufacturing focus suggests opportunities in workforce training, compliance, safety programs, and knowledge transfer services for radiopharmaceutical production.